Q3 2026 Cannabis Investor Briefing
Federal landscape, state regulatory shifts, M&A activity, and tax/banking — exclusively for cannabis-investment funds
Reserve your seat
$1,500/seat
Includes:
- 90-minute virtual session
- Pre-briefing packet (PDF, 24h before)
- Full recording + transcript (48h after)
- Live Q&A with Bob Hoban
Session agenda
DEA Schedule III NPRM status, SAFE Banking Act prospects, IRS/280E enforcement posture, and Congressional cannabis activity since last quarter.
New market openings, license application windows, social equity program updates, and enforcement pattern changes in 12 priority states.
Q-over-Q deal flow analysis, valuation multiples, license-transfer mechanics, distressed asset opportunities, and notable transactions.
§471(c) safe harbor litigation, IRC §280E successor liability in M&A, FinCEN guidance evolution, and payment rails landscape.
Open Q&A with Bob Hoban. Submit questions in advance at registration or ask live during the session.